These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25368235)

  • 1. Immunogenic modulation of cholangiocarcinoma cells by chemoimmunotherapy.
    Koido S; Kan S; Yoshida K; Yoshizaki S; Takakura K; Namiki Y; Tsukinaga S; Odahara S; Kajihara M; Okamoto M; Ito M; Yusa S; Gong J; Sugiyama H; Ohkusa T; Homma S; Tajiri H
    Anticancer Res; 2014 Nov; 34(11):6353-61. PubMed ID: 25368235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I/II-restricted epitopes for pancreatic cancer.
    Koido S; Homma S; Okamoto M; Takakura K; Mori M; Yoshizaki S; Tsukinaga S; Odahara S; Koyama S; Imazu H; Uchiyama K; Kajihara M; Arakawa H; Misawa T; Toyama Y; Yanagisawa S; Ikegami M; Kan S; Hayashi K; Komita H; Kamata Y; Ito M; Ishidao T; Yusa S; Shimodaira S; Gong J; Sugiyama H; Ohkusa T; Tajiri H
    Clin Cancer Res; 2014 Aug; 20(16):4228-39. PubMed ID: 25056373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The case of a patient with peritoneal metastasis from cholangiocarcinoma who responded to adoptive immunotherapy and cetuximab].
    Kan N; Yoshikawa K; Matsushita N; Fujii T
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1759-61. PubMed ID: 24393913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Factors for Survival in Patients with Advanced Intrahepatic Cholangiocarcinoma Treated with Gemcitabine plus Cisplatin as First-Line Treatment.
    Ishimoto U; Kondo S; Ohba A; Sasaki M; Sakamoto Y; Morizane C; Ueno H; Okusaka T
    Oncology; 2018; 94(2):72-78. PubMed ID: 29017161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic gemcitabine combined with hepatic arterial infusion chemotherapy with cisplatin, 5-fluorouracil, and isovorin for the treatment of advanced intrahepatic cholangiocarcinoma: a pilot study.
    Marumoto M; Yamasaki T; Marumoto Y; Saeki I; Harima Y; Urata Y; Hidaka I; Ishikawa T; Takami T; Segawa M; Yamaguchi Y; Uchida K; Terai S; Sakaida I
    Hepatogastroenterology; 2014; 61(129):162-7. PubMed ID: 24895814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential efficacy of hepatic arterial infusion chemotherapy using gemcitabine, cisplatin, and 5-fluorouracil for intrahepatic cholangiocarcinoma.
    Ishii M; Itano O; Morinaga J; Shirakawa H; Itano S
    PLoS One; 2022; 17(4):e0266707. PubMed ID: 35452492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch1 is overexpressed in human intrahepatic cholangiocarcinoma and is associated with its proliferation, invasiveness and sensitivity to 5-fluorouracil in vitro.
    Wu WR; Zhang R; Shi XD; Zhu MS; Xu LB; Zeng H; Liu C
    Oncol Rep; 2014 Jun; 31(6):2515-24. PubMed ID: 24700253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External beam radiation therapy with or without concurrent chemotherapy for patients with unresectable locally advanced hilar cholangiocarcinoma.
    Chen SC; Chen MH; Li CP; Chen MH; Chang PM; Liu CY; Tzeng CH; Liu YM; Yen SH; Chao Y; Huang PI
    Hepatogastroenterology; 2015; 62(137):102-7. PubMed ID: 25911877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Programmed Death Ligand 1 Is Associated with the Prognosis of Intrahepatic Cholangiocarcinoma.
    Dong Z; Liao B; Shen W; Sui C; Yang J
    Dig Dis Sci; 2020 Feb; 65(2):480-488. PubMed ID: 31410753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
    Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
    Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrahepatic cholangiocarcinoma with lymph node metastasis successfully treated by immunotherapy with CD3-activated T cells and dendritic cells after surgery: report of a case.
    Higuchi R; Yamamoto M; Hatori T; Shimizu K; Imai K; Takasaki K
    Surg Today; 2006; 36(6):559-62. PubMed ID: 16715430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced cytotoxic activity of effector T-cells against cholangiocarcinoma by dendritic cells pulsed with pooled mRNA.
    Junking M; Grainok J; Thepmalee C; Wongkham S; Yenchitsomanus PT
    Tumour Biol; 2017 Oct; 39(10):1010428317733367. PubMed ID: 29034817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local and abscopal responses in advanced intrahepatic cholangiocarcinoma with low TMB, MSS, pMMR and negative PD-L1 expression following combined therapy of SBRT with PD-1 blockade.
    Liu X; Yao J; Song L; Zhang S; Huang T; Li Y
    J Immunother Cancer; 2019 Aug; 7(1):204. PubMed ID: 31383016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed response to maintenance therapy after first-line chemotherapy in metastatic intrahepatic cholangiocarcinoma: a case report.
    Marciano R; Servetto A; Bianco C; Bianco R
    J Med Case Rep; 2017 Sep; 11(1):273. PubMed ID: 28946921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinoma.
    Ding DY; Gan XJ; Zhang JN; Hou GJ; Tao QF; Sun DP; Li W; Yang Y; Ding WB; Yu J; Liu L; Yang F; Zhou WP; Yuan SX
    Br J Cancer; 2023 Mar; 128(5):907-917. PubMed ID: 36526676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell-based immunotherapy targeting synthesized peptides for advanced biliary tract cancer.
    Kobayashi M; Sakabe T; Abe H; Tanii M; Takahashi H; Chiba A; Yanagida E; Shibamoto Y; Ogasawara M; Tsujitani S; Koido S; Nagai K; Shimodaira S; Okamoto M; Yonemitsu Y; Suzuki N; Nagaya M;
    J Gastrointest Surg; 2013 Sep; 17(9):1609-17. PubMed ID: 23877328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of bilateral metal stenting and trans-stent photodynamic therapy for palliative treatment of hilar cholangiocarcinoma.
    Gerhardt T; Rings D; Höblinger A; Heller J; Sauerbruch T; Schepke M
    Z Gastroenterol; 2010 Jan; 48(1):28-32. PubMed ID: 20072993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor outcomes after liver transplantation in patients with incidental cholangiocarcinoma irrespective of tumor localization.
    Patkowski W; Stankiewicz R; Grąt M; Krasnodębski M; Kornasiewicz O; Krawczyk M
    Transplant Proc; 2014 Oct; 46(8):2774-6. PubMed ID: 25380915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of hepatic arterial infusion chemotherapy using 5-fluorouracil and systemic pegylated interferon α-2b for advanced intrahepatic cholangiocarcinoma.
    Kasai K; Kooka Y; Suzuki Y; Suzuki A; Oikawa T; Ushio A; Kasai Y; Sawara K; Miyamoto Y; Oikawa K; Takikawa Y
    Ann Surg Oncol; 2014 Oct; 21(11):3638-45. PubMed ID: 24817369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HBV-associated intrahepatic cholangiocarcinoma with high serum alpha-fetoprotein: a case report with review of literature.
    Wang C; Jing H; Sha D; Wang W; Chen J; Cui Y; Han J
    BMC Infect Dis; 2016 Jun; 16():295. PubMed ID: 27301956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.